U.S. Osteoarthritis Injectables Market (2024 - 2030) Size, Share & Trends Analysis Report By Injection Type (Hyaluronic Acid Injections, Corticosteroids Injections), By Anatomy (Knee Osteoarthritis, Hip Osteoarthritis), By End-use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Injection Type
                        1.2.2. End-use
                        1.2.3. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Injection Type
                        2.2.2. End-use
                    2.3. Competitive Insights
Chapter 3. U.S. Osteoarthritis Injectables Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Increasing prevalence of osteoarthritis
                            3.2.1.2. Growing geriatric population susceptible to osteoarthritis
                            3.2.1.3. Increase in R&D activities for injectable drug development
                        3.2.2. Market restraint analysis
                            3.2.2.1. Adoption of other treatment options
                            3.2.2.2. High cost of treatment
                            3.3. U.S. Osteoarthritis Injectables Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s Five Forces
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                            3.3.2.4. Pricing Analysis
                        3.3.3. Pricing Analysis
Chapter 4. U.S. Osteoarthritis Injectables Market: Injection Type Estimates & Trend Analysis
                    4.1. U.S. Osteoarthritis Injectables Market: Injection Type Dashboard
                    4.2. U.S. Osteoarthritis Injectables Market: Injection Type Movement Analysis
                    4.3. U.S. Osteoarthritis Injectables Market Estimates and Forecasts, By Injection Type, Revenue (USD Million)
                    4.4. Hyaluronic Acid Injections
                        4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.5. Corticosteroid Injections
                        4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.6. Platelet-rich Plasma (PRP) Injections
                        4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.7. Placental Tissue Matrix (PTM) Injections
                        4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.8. Acetylsalicylic Acid (ASA) Injections
                        4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.9. Others
                        4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Osteoarthritis Injectables Market: Anatomy Estimates & Trend Analysis
                    5.1. U.S. Osteoarthritis Injectables Market: Anatomy Dashboard
                    5.2. U.S. Osteoarthritis Injectables Market: Anatomy Movement Analysis
                    5.3. U.S. Osteoarthritis Injectables Market Estimates and Forecasts, By Anatomy, Revenue (USD Million)
                    5.4. Knee Osteoarthritis
                        5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.5. Hip Osteoarthritis
                        5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.6. Hand Osteoarthritis
                        5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.7. Others
                        5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Osteoarthritis Injectables Market: End-use Estimates & Trend Analysis
                    6.1. U.S. Osteoarthritis Injectables Market: End-use Dashboard
                    6.2. U.S. Osteoarthritis Injectables Market: End-use Movement Analysis
                    6.3. U.S. Osteoarthritis Injectables Market Estimates and Forecasts, By End-use, Revenue (USD Million)
                    6.4. Hospital Pharmacies
                        6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.5. Retail Pharmacies
                        6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.6. Others
                        6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                    7.4. Company Profiles
                        7.4.1. Anika Therapeutics, Inc.
                            7.4.1.1. Company overview
                            7.4.1.2. Financial performance
                            7.4.1.3. Product benchmarking
                            7.4.1.4. Strategic initiatives
                        7.4.2. Bioventus.
                            7.4.2.1. Company overview
                            7.4.2.2. Financial performance
                            7.4.2.3. Product benchmarking
                            7.4.2.4. Strategic initiatives
                        7.4.3. Ferring Pharmaceuticals Inc.
                            7.4.3.1. Company overview
                            7.4.3.2. Financial performance
                            7.4.3.3. Product benchmarking
                            7.4.3.4. Strategic initiatives
                        7.4.4. Sanofi S.A.
                            7.4.4.1. Company overview
                            7.4.4.2. Financial performance
                            7.4.4.3. Product benchmarking
                            7.4.4.4. Strategic initiatives
                        7.4.5. Flexion Therapeutics, Inc.
                            7.4.5.1. Company overview
                            7.4.5.2. Financial performance
                            7.4.5.3. Product benchmarking
                            7.4.5.4. Strategic initiatives
                        7.4.6. Zimmer Biomet
                            7.4.6.1. Company overview
                            7.4.6.2. Financial performance
                            7.4.6.3. Product benchmarking
                            7.4.6.4. Strategic initiatives
                        7.4.7. Arthrex, Inc.
                            7.4.7.1. Company overview
                            7.4.7.2. Financial performance
                            7.4.7.3. Product benchmarking
                            7.4.7.4. Strategic initiatives
                        7.4.8. Royal Biologics
                            7.4.8.1. Company overview
                            7.4.8.2. Financial performance
                            7.4.8.3. Product benchmarking
                            7.4.8.4. Strategic initiatives
                        7.4.9. Teva Pharmaceutical Industries Ltd.
                            7.4.9.1. Company overview
                            7.4.9.2. Financial performance
                            7.4.9.3. Product benchmarking
                            7.4.9.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Pipeline analysis, osteoarthritis injectables
Table 4 Pricing of key injectable drugs/therapies
Table 5 U.S. osteoarthritis injectables market revenue estimates and forecast, by injection type, 2018 - 2030 (USD Million)
Table 6 U.S. osteoarthritis injectables market revenue estimates and forecast, by anatomy, 2018 - 2030 (USD Million)
Table 7 U.S. osteoarthritis injectables market revenue estimates and forecast, by end use, 2018 - 2030 (USD Million)
Table 8 Company market share, 2023
Table 9 List of players adopting acquisition strategy
Table 10 Key companies undergoing partnership & collaborations.
Table 11 Key companies receiving approvals.
Table 12 Key companies undertaking other activities.

List of Figures

Fig. 1 U.S. osteoarthritis injectables market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Injection type and anatomy segment snapshot
Fig. 10 End-use segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market (USD billion)
Fig. 13 U.S. osteoarthritis injectables market dynamics
Fig. 14 Prevalence of osteoarthritis in the U.S., by type
Fig. 15 U.S. population aged 65 and above, by years (Million)
Fig. 16 U.S. pharmaceuticals registration details
Fig. 17 U.S. drug pricing
Fig. 18 U.S. osteoarthritis injectables market: PORTER’s analysis
Fig. 19 U.S. osteoarthritis injectables market: PESTLE analysis
Fig. 20 U.S. osteoarthritis injectables market: Injection type outlook and key takeaways
Fig. 21 U.S. osteoarthritis injectables market: Injection type movement analysis
Fig. 22 Corticosteroid injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Hyaluronic acid injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Platelet-rich Plasma (PRP) injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Placental Tissue Matrix (PTM) injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Acetylsalicylic Acid (ASA) injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 U.S. osteoarthritis injectables market: Anatomy outlook and key takeaways
Fig. 29 U.S. osteoarthritis injectables market: Anatomy movement analysis
Fig. 30 Knee osteoarthritis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Hip osteoarthritis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Hand osteoarthritis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 U.S. osteoarthritis injectables market: End-use outlook and key takeaways
Fig. 35 U.S. osteoarthritis injectables market: End-use movement analysis
Fig. 36 Hospitals pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Others market estimates and forecast, 2018 - 2030 (USD Million)